(S-184) Singbartl, K., Saturday 9:15
TITLE: FIBRINOGEN AND ACUTE HEMODILUTION: A MATHEMATICAL ANALYSIS
AUTHORS: Kai Singbartl, MD1, Jens Radvan, MSc2, Ingo Heschel, MSc2, Wolfgang Schleinzer, MD3, Guenter Singbartl, MD4
AFFILIATION: 1WWU Muenster, Germany, Charlottesville, VA; 2RWTH, Aachen, Germany; 3SPZ, Nottwil, Switzerland; 4ENDO-Klinik, Hamburg, Germany.
INTRODUCTION: Acute hemodilution (HD) has often been accused to increase bleeding. Clear scientific evidence for this is lacking so far. In vitro studies revealed a colloid specific effect rather than a clear dilution-induced one. Overlooking these 'drug effects', we present a mathematical model (MM) for acute normovolemic hemodilution (ANH) and no preoperative hemodilution (no HD) describing the course of fibrinogen as part of blood coagulation.
METHODS: Our MM is based on exponential decline of fibrinogen concentration (Fib, in mg/dl) and hematocrit (hct) during isovolemic blood substitution (colloid, volume effect 1.0). Body weight (BW)=70kg, blood volume=70ml/kg BW and 200ml colloidal preload are assumed. ANH includes exchanging 4*500ml blood vs. colloid and retransfusing ANH blood together with colloid to maintain minimal acceptable Fib (Fibm) or minimal acceptable hct (hctm).
RESULTS: We validated our model by recalculating inde- pendent clinical data [1] (Tab.1). Tab.2 (initial hct=45%) gives final Fib for several minimal acceptable hct (hctm) and different initial Fib (Fibi) during HD (identical for ANH and no HD). Tab.3 (initial hct=45%) gives maximal allowable blood losses (MABL) with respect to Fibm.
DISCUSSION: Our validated MM indicates that with Fibi in the upper normal range HD does not induce 'coagulation relevant' fibrinogen depletion (FD), as for all hctm calculated final Fib>critical Fibm. By contrast, with Fibi in the lower normal range severe, 'coagulation relevant' FD could occur. Also, with respect to MABL ANH appears to save fibrinogen when com- pared to no HD.
TABLE 1: Validation of MM by recalculating clinical data [1].
|
|
Fibrinogen (mg/dl) |
|
|
clinical data (mean±SD) [1] |
recalculated data |
|
|
before ANH |
360±70 |
360 |
|
after ANH |
260±50 |
256 |
TABLE 2: Final Fib (mg/dl) for various Fibi and hctm.
|
|
hctm |
|||
|
Fibi (mg/dl) |
27% |
24% |
21% |
18% |
|
450 |
203 |
174 |
146 |
121 |
|
200 |
90 |
77 |
65 |
54 |
TABLE 3: MABL (ml) with respect to Fibm.
|
|
Fibi=450mg/dl |
Fibi=200mg/dl |
||
|
Fibm (mg/dl) |
ANH |
no HD |
ANH |
no HD |
|
80 |
9885 |
5399 |
3765 |
2864 |
REFERENCES:
1) Br J Anaesth 1996 76:519-25.